4.7 Review

Targeting vascular (endothelial) dysfunction

期刊

BRITISH JOURNAL OF PHARMACOLOGY
卷 174, 期 12, 页码 1591-1619

出版社

WILEY
DOI: 10.1111/bph.13517

关键词

-

资金

  1. European Cooperation in Science and Technology (COST Action) [BM1203/EU-ROS]
  2. Stiftung Mainzer Herz
  3. Centre of Translational Vascular Biology (CTVB)
  4. Johannes Gutenberg University Mainz
  5. Institute of Molecular Biology gGmbH, (Mainz, Germany) - Boehringer Ingelheim Foundation

向作者/读者索取更多资源

Cardiovascular diseases are major contributors to global deaths and disability-adjusted life years, with hypertension a significant risk factor for all causes of death. The endothelium that lines the inner wall of the vasculature regulates essential haemostatic functions, such as vascular tone, circulation of blood cells, inflammation and platelet activity. Endothelial dysfunction is an early predictor of atherosclerosis and future cardiovascular events. We review the prognostic value of obtaining measurements of endothelial function, the clinical techniques for its determination, the mechanisms leading to endothelial dysfunction and the therapeutic treatment of endothelial dysfunction. Since vascular oxidative stress and inflammation are major determinants of endothelial function, we have also addressed current antioxidant and anti-inflammatory therapies. In the light of recent data that dispute the prognostic value of endothelial function in healthy human cohorts, we also discuss alternative diagnostic parameters such as vascular stiffness index and intima/media thickness ratio. We also suggest that assessing vascular function, including that of smooth muscle and even perivascular adipose tissue, may be an appropriate parameter for clinical investigations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据